![Wlodzimierz Stepkowski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Wlodzimierz Stepkowski
Direktor/Vorstandsmitglied bei CANNABIS POLAND S.A.
Aktive Positionen von Wlodzimierz Stepkowski
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CANNABIS POLAND S.A. | Direktor/Vorstandsmitglied | - | - |
GARIN S.A. | Corporate Officer/Principal | 01.04.2015 | - |
ERNE VENTURES SA | Corporate Officer/Principal | 01.04.2015 | - |
POLSKA GRUPA MILITARNA SPÓLKA AKCYJNA | Direktor/Vorstandsmitglied | - | - |
HEMP & HEALTH S.A. | Direktor/Vorstandsmitglied | - | - |
Telehorse Sp zoo
![]() Telehorse Sp zoo Packaged SoftwareTechnology Services Telehorse Sp zoo engages in the design of software. The company was founded on June 18, 2013 and is headquartered in Warsaw, Poland. | Direktor/Vorstandsmitglied | - | - |
Super Liquid SA | Direktor/Vorstandsmitglied | 01.01.2017 | - |
Karriereverlauf von Wlodzimierz Stepkowski
Ehemalige bekannte Positionen von Wlodzimierz Stepkowski
Unternehmen | Position | Beginn | Ende |
---|
Statistik
International
Polen | 8 |
Operativ
Director/Board Member | 5 |
Corporate Officer/Principal | 3 |
Sektoral
Technology Services | 3 |
Health Technology | 2 |
Consumer Durables | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
CANNABIS POLAND S.A. | Health Technology |
GARIN S.A. | Consumer Durables |
POLSKA GRUPA MILITARNA SPÓLKA AKCYJNA | Technology Services |
HEMP & HEALTH S.A. | Commercial Services |
Private Unternehmen | 3 |
---|---|
Telehorse Sp zoo
![]() Telehorse Sp zoo Packaged SoftwareTechnology Services Telehorse Sp zoo engages in the design of software. The company was founded on June 18, 2013 and is headquartered in Warsaw, Poland. | Technology Services |
Erne Ventures SA
![]() Erne Ventures SA Specialty StoresRetail Trade Erne Ventures SA is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; RX-5902 or Supinoxin for metastatic triple negative breast cancer; and RX-0201 or Archexin for renal cell carcinoma, glioblastoma, ovarian, stomach, and pancreatic cancer. It also develops nano-based drug delivery systems. The company was founded by Arkadiusz Stefan Kuich in September 2007 and is headquartered in Warszawa, Poland. | Retail Trade |
Super Liquid SA |
- Börse
- Insiders
- Wlodzimierz Stepkowski
- Erfahrung